Progestins initiate adverse events of menopausal estrogen therapy

Author： Thomas T.   Rhodin J.   Clark L.   Garces A.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.6, Iss.4, 2003-12, pp. : 293-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parenteral administration of progestins for hormonal replacement therapy

By Nath Anita   Sitruk-Ware Regine  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 2, 2009-04 ,pp. : 88-96

Informa Healthcare

Access to resources Recommend Favorite

Estrogen and progestogen effect on venous thromboembolism in menopausal women

By Archer D. F.   Oger E.  

Climacteric, Vol. 15, Iss. 3, 2012-06 ,pp. : 235-240

Informa Healthcare

Access to resources Recommend Favorite

Circulating microparticles and endogenous estrogen in newly menopausal women

By Jayachandran M.   Litwiller R. D.   Owen W. G.   Miller V. M.  

Climacteric, Vol. 12, Iss. 2, 2009-04 ,pp. : 177-184

Informa Healthcare

Access to resources Recommend Favorite

Menopausal hormone therapy: a paradigm shift?

By Liu J.H.  

Fertility and Sterility, Vol. 80, Iss. 3, 2003-09 ,pp. : 494-495

Elsevier

Access to resources Recommend Favorite

Prevalence of estrogen or estrogen-progestin hormone therapy use

By Brett K.M.   Reuben C.A.  

Obstetrics and Gynecology, Vol. 102, Iss. 6, 2003-12 ,pp. : 1240-1249

Elsevier

Access to resources Recommend Favorite